Ocular aldehyde dehydrogenases: Protection against ultraviolet damage and maintenance of transparency for vision

Progress in Retinal and Eye Research

Volumn 33, Issue 1, 2013, Pages 28-39

  Chen, Ying ^a   Thompson, David C ^a   Koppaka, Vindhya ^a   Jester, James V ^b   Vasiliou, Vasilis ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ALDH; Cataract; Cornea; Crystallin; Lens; Transparency; Ultraviolet damage

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; ALDEHYDE DEHYDROGENASE 1A8; ALDEHYDE DEHYDROGENASE 1A9; ALDEHYDE DEHYDROGENASE 1C1; ALDEHYDE DEHYDROGENASE 1C2; ALDEHYDE DEHYDROGENASE 3A1; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CRYSTALLIN; LIPID HYDROPEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OCTAMER TRANSCRIPTION FACTOR 1; RETINAL DEHYDROGENASE; RETINOIC ACID; UNCLASSIFIED DRUG;

BLINDNESS; CATALYSIS; CATARACT; CELL PROLIFERATION; CONGENITAL CATARACT; CONJUNCTIVAL DEPOSIT; CORNEA; CORNEA CELL; DISEASE ASSOCIATION; EPITHELIUM CELL; EYE DEVELOPMENT; EYE DISEASE; LENS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PTERYGIUM; RABBIT; RADIATION INJURY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; ULTRAVIOLET RADIATION; VISION;

ALDEHYDE DEHYDROGENASE; ANIMALS; CORNEA; EYE INJURIES; HUMANS; LENS, CRYSTALLINE; ULTRAVIOLET RAYS;

EID: 84873465688     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.10.001     Document Type: Review

References (127)

1. Abedinia M., Pain T., Algar E.M., Holmes R.S. Bovine corneal aldehyde dehydrogenase: the major soluble corneal protein with a possible dual protective role for the eye. Exp. Eye Res. 1990, 51:419-426.
2. Aikens J., Dix T.A. Perhydroxyl radical (HOO) initiated lipid peroxidation. The role of fatty acid hydroperoxides. J. Biol. Chem. 1991, 266:15091-15098.
3. Allen E.M., Anderson D.G., Florang V.R., Khanna M., Hurley T.D., Doorn J.A. Relative inhibitory potency of molinate and metabolites with aldehyde dehydrogenase 2: implications for the mechanism of enzyme inhibition. Chem. Res. Toxicol. 2010, 23:1843-1850.
4. Andley U.P., Rhim J.S., Chylack L.T., Fleming T.P. Propagation and immortalization of human lens epithelial cells in culture. Invest. Ophthalmol. Vis. Sci. 1994, 35:3094-3102.
5. Atherton S.J., Lambert C., Schultz J., Williams N., Zigman S. Fluorescence studies of lens epithelial cells and their constituents. Photochem. Photobiol. 1999, 70:823-828.
6. Balasubramanian D. Ultraviolet radiation and cataract. J. Ocul. Pharmacol. Ther. 2000, 16:285-297.
7. Barrera G., Pizzimenti S., Dianzani M.U. 4-Hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radic. Biol. Med. 2004, 37:597-606.
8. Beales M.P., Funderburgh J.L., Jester J.V., Hassell J.R. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest. Ophthalmol. Vis. Sci. 1999, 40:1658-1663.
9. Benedek G.B. Theory of transparency of the eye. Appl. Opt. 1971, 10:459-473.
10. Bergendi L., Benes L., Durackova Z., Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 1999, 65:1865-1874.
11. Bergmanson J.P., Soderberg P.G. The significance of ultraviolet radiation for eye diseases. A review with comments on the efficacy of UV-blocking contact lenses. Ophthalmic Physiol. Opt. 1995, 15:83-91.
12. Bhat P.V., Samaha H. Kinetic properties of the human liver cytosolic aldehyde dehydrogenase for retinal isomers. Biochem. Pharmacol. 1999, 57:195-197.
13. Bhuyan K.C., Bhuyan D.K., Santos O., Podos S.M. Antioxidant and anticataractogenic effects of topical captopril in diquat-induced cataract in rabbits. Free Radic. Biol. Med. 1992, 12:251-261.
14. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol. Chem. 2006, 387:1329-1335.
15. Brocker C., Lassen N., Estey T., Pappa A., Cantore M., Orlova V.V., Chavakis T., Kavanagh K.L., Oppermann U., Vasiliou V. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J. Biol. Chem. 2010, 285:18452-18463.
16. Buddi R., Lin B., Atilano S.R., Zorapapel N.C., Kenney M.C., Brown D.J. Evidence of oxidative stress in human corneal diseases. J. Histochem. Cytochem. 2002, 50:341-351.
17. Burke W.J., Li S.W., Williams E.A., Nonneman R., Zahm D.S. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis. Brain Res. 2003, 989:205-213.
18. Cadenas E., Sies H. The lag phase. Free Radic. Res. 1998, 28:601-609.
19. Cai X., McGinnis J.F. Oxidative stress: the achilles' heel of neurodegenerative diseases of the retina. Front. Biosci. 2012, 17:1976-1995.
20. Chalam K.V., Khetpal V., Rusovici R., Balaiya S. A review: role of ultraviolet radiation in age-related macular degeneration. Eye Contact Lens 2011, 37:225-232.
21. Chen Y., Koppaka V., Thompson D.C., Vasiliou V. Focus on Molecules: ALDH1A1: From lens and corneal crystallin to stem cell marker. Exp. Eye Res. 2011, 102:105-106.
22. Chen Y., Mehta G., Vasiliou V. Antioxidant defenses in the ocular surface. Ocul. Surf. 2009, 7:176-185.
23. Chen Y., Orlicky D.J., Matsumoto A., Singh S., Thompson D.C., Vasiliou V. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. Biochem. Biophys. Res. Commun. 2011, 405:173-179.
24. Choudhary S., Xiao T., Vergara L.A., Srivastava S., Nees D., Piatigorsky J., Ansari N.H. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest. Ophthalmol. Vis. Sci. 2005, 46:259-267.
25. Cobessi D., Tete-Favier F., Marchal S., Branlant G., Aubry A. Structural and biochemical investigations of the catalytic mechanism of an NADP-dependent aldehyde dehydrogenase from Streptococcus mutans. J. Mol. Biol. 2000, 300:141-152.
26. Colby T.D., Bahnson B.J., Chin J.K., Klinman J.P., Goldstein B.M. Active site modifications in a double mutant of liver alcohol dehydrogenase: structural studies of two enzyme-ligand complexes. Biochemistry 1998, 37:9295-9304.
27. Cooper D.L., Isola N.R., Stevenson K., Baptist E.W. Members of the ALDH gene family are lens and corneal crystallins. Adv. Exp. Med. Biol. 1993, 328:169-179.
28. Cvekl A., Piatigorsky J. Lens development and crystallin gene expression: many roles for Pax-6. BioEssays 1996, 18:621-630.
29. Cvekl A., Sax C.M., Li X., McDermott J.B., Piatigorsky J. Pax-6 and lens-specific transcription of the chicken delta 1-crystallin gene. Proc. Natl. Acad. Sci. U S A 1995, 92:4681-4685.
30. D'Ambrosio K., Pailot A., Talfournier F., Didierjean C., Benedetti E., Aubry A., Branlant G., Corbier C. The first crystal structure of a thioacylenzyme intermediate in the ALDH family: new coenzyme conformation and relevance to catalysis. Biochemistry 2006, 45:2978-2986.
31. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001, 83:301-310.
32. Davies M.J., Truscott R.J. Photo-oxidation of proteins and its role in cataractogenesis. J. Photochem. Photobiol. B 2001, 63:114-125.
33. Davis J., Davis D., Norman B., Piatigorsky J. Gene expression of the mouse corneal crystallin Aldh3a1: activation by Pax6, Oct1, and p300. Invest. Ophthalmol. Vis. Sci. 2008, 49:1814-1826.
34. Dean R.T., Fu S., Stocker R., Davies M.J. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 1997, 324(Pt 1):1-18.
35. Delaye M., Tardieu A. Short-range order of crystallin proteins accounts for eye lens transparency. Nature 1983, 302:415-417.
36. Deng S., Yang X., Lassus H., Liang S., Kaur S., Ye Q., Li C., Wang L.P., Roby K.F., Orsulic S., Connolly D.C., Zhang Y., Montone K., Butzow R., Coukos G., Zhang L. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS. One 2010, 5:e10277.
37. Dianzani M.U. 4-Hydroxynonenal and cell signalling. Free Radic. Res. 1998, 28:553-560.
38. Dickinson D.A., Forman H.J. Glutathione in defense and signaling: lessons from a small thiol. Ann. N. Y. Acad. Sci. 2002, 973:488-504.
39. Downes J.E., Swann P.G., Holmes R.S. Ultraviolet light-induced pathology in the eye: associated changes in ocular aldehyde dehydrogenase and alcohol dehydrogenase activities. Cornea 1993, 12:241-248.
40. Downes J.E., Swann P.G., Holmes R.S. A genetic basis for corneal sensitivity to ultraviolet light among recombinant SWXJ inbred strains of mice. Curr. Eye Res. 1997, 16:539-546.
41. Downes J.E., VandeBerg J.L., Hubbard G.B., Holmes R.S. Regional distribution of mammalian corneal aldehyde dehydrogenase and alcohol dehydrogenase. Cornea 1992, 11:560-566.
42. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 2000, 267:4315-4324.
43. Duester G. Keeping an eye on retinoic acid signaling during eye development. Chem. Biol. Interact. 2009, 178:178-181.
44. Duester G., Mic F.A., Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem. Biol. Interact. 2003, 143-144:201-210.
45. Dupe V., Matt N., Garnier J.M., Chambon P., Mark M., Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. U S A 2003, 100:14036-14041.
46. Eaton J.W. UV-mediated cataractogenesis: a radical perspective. Doc. Ophthalmol. 1994, 88:233-242.
47. Eguchi G. Crystalline lens. Tanpakushitsu Kakusan Koso 1966, 11:1083-1084.
48. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 1993, 57:779S-785S.
49. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
50. Estey T., Cantore M., Weston P.A., Carpenter J.F., Petrash J.M., Vasiliou V. Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1. J. Biol. Chem. 2007, 282:4382-4392.
51. Estey T., Chen Y., Carpenter J.F., Vasiliou V. Structural and functional modifications of corneal crystallin ALDH3A1 by UVB light. PLoS. One 2010, 5:e15218.
52. Estey T., Piatigorsky J., Lassen N., Vasiliou V. ALDH3A1: a corneal crystallin with diverse functions. Exp. Eye Res. 2007, 84:3-12.
53. Fan X., Molotkov A., Manabe S., Donmoyer C.M., Deltour L., Foglio M.H., Cuenca A.E., Blaner W.S., Lipton S.A., Duester G. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell. Biol. 2003, 23:4637-4648.
54. Finkel T. Signal transduction by reactive oxygen species. J. Cell. Biol. 2011, 194:7-15.
55. Forni L.G., Willson R.L. Thiyl free radicals and the oxidation of ferrocytochrome c. Direct observation of coupled hydrogen-atom- and electron-transfer reactions. Biochem. J. 1986, 240:905-907.
56. Galbis-Estrada C., Pons-Vazquez S., Gallego-Pinazo R., Lleo-Perez A., Garcia-Medina J.J., Bou V.V., Sanz-Solana P., Pinazo-Duran M.D. Glutathione-dependent formaldehyde dehydrogenase (ADH3) and low km mitochondrial aldehyde dehydrogenase (ALDH2). New evidence for differential expression in the rat retina in response to oxidative stress. Free Radic. Res. 2012, 46:77-84.
57. Gasparetto M., Sekulovic S., Brocker C., Tang P., Zakaryan A., Xiang P., Kuchenbauer F., Wen M., Kasaian K., Witty M.F., Rosten P., Chen Y., Imren S., Duester G., Thompson D.C., Humphries R.K., Vasiliou V., Smith C. Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development. Exp. Hematol. 2011, 40(4):318-329.
58. Gehring W.J., Ikeo K. Pax 6: mastering eye morphogenesis and eye evolution. Trends Genet. 1999, 15:371-377.
59. Gondhowiardjo T.D., van Haeringen N.J., Volker-Dieben H.J., Beekhuis H.W., Kok J.H., van R.G., Pels L., Kijlstra A. Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea 1993, 12:146-154.
60. Graham C., Hodin J., Wistow G. A retinaldehyde dehydrogenase as a structural protein in a mammalian eye lens. Gene recruitment of eta-crystallin. J. Biol. Chem. 1996, 271:15623-15628.
61. Halliwell B. Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic. Res. 1998, 29:469-486.
62. Hanna M.C., Blackstone C. Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1. Neurogenetics 2009, 10:217-228.
63. Holmes R.S., Cheung B., VandeBerg J.L. Isoelectric focusing studies of aldehyde dehydrogenases, alcohol dehydrogenases and oxidases from mammalian anterior eye tissues. Comp. Biochem. Physiol. B 1989, 93:271-277.
64. Hough R.B., Piatigorsky J. Preferential transcription of rabbit Aldh1a1 in the cornea: implication of hypoxia-related pathways. Mol. Cell. Biol. 2004, 24:1324-1340.
65. Jackson B., Brocker C., Thompson D.C., Black W., Vasiliou K., Nebert D.W., Vasiliou V. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum. Genomics 2011, 5:283-303.
66. Jester J.V. Corneal crystallins and the development of cellular transparency. Semin. Cell. Dev. Biol. 2008, 19:82-93.
67. Jester J.V., Brown D., Pappa A., Vasiliou V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering. Invest. Ophthalmol. Vis. Sci. 2012, 53:770-778.
68. Jester J.V., Budge A., Fisher S., Huang J. Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering. Invest. Ophthalmol. Vis. Sci. 2005, 46:2369-2378.
69. Jester J.V., Moller-Pedersen T., Huang J., Sax C.M., Kays W.T., Cavangh H.D., Petroll W.M., Piatigorsky J. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J. Cell. Sci. 1999, 112(Pt 5):613-622.
70. Johnson F., Giulivi C. Superoxide dismutases and their impact upon human health. Mol. Aspects Med. 2005, 26:340-352.
71. Kazmi S.M., Li D., Koop K., Conant J., Lau C.Y. Role of aldehyde dehydrogenase in the biological activity of spermine dialdehyde, a novel immunosuppressive/purging agent. Pharmacol. Res. 1992, 25:383-392.
72. King G., Holmes R.S. Human corneal aldehyde dehydrogenase: purification, kinetic characterisation and phenotypic variation. Biochem. Mol. Biol. Int. 1993, 31:49-63.
73. Kirsch M., De G.H. NAD(P)H, a directly operating antioxidant?. FASEB J. 2001, 15:1569-1574.
74. Klein R.S., Werth V.P., Dowdy J.C., Sayre R.M. Analysis of compact fluorescent lights for use by patients with photosensitive conditions. Photochem. Photobiol. 2009, 85:1004-1010.
75. Klyosov A.A., Rashkovetsky L.G., Tahir M.K., Keung W.M. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 1996, 35:4445-4456.
76. Kolozsvari L., Nogradi A., Hopp B., Bor Z. UV absorbance of the human cornea in the 240- to 400-nm range. Invest. Ophthalmol. Vis. Sci. 2002, 43:2165-2168.
77. Lassen N., Bateman J.B., Estey T., Kuszak J.R., Nees D.W., Piatigorsky J., Duester G., Day B.J., Huang J., Hines L.M., Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J. Biol. Chem. 2007, 282:25668-25676.
78. Lassen N., Black W.J., Estey T., Vasiliou V. The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. Semin. Cell. Dev. Biol. 2008, 19:100-112.
79. Lassen N., Pappa A., Black W.J., Jester J.V., Day B.J., Min E., Vasiliou V. Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts. Free Radic. Biol. Med. 2006, 41:1459-1469.
80. Leonard S.S., Harris G.K., Shi X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med. 2004, 37:1921-1942.
81. Liu Z.J., Hempel J., Sun J., Rose J., Hsiao D., Chang W.R., Chung Y.J., Kuo I., Lindahl R., Wang B.C. Crystal structure of a class 3 aldehyde dehydrogenase at 2.6 A resolution. Adv. Exp. Med. Biol. 1997, 414:1-7.
82. Ma I., Allan A.L. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell. Rev. 2011, 7(2):292-306.
83. Mackenzie F.D., Hirst L.W., Battistutta D., Green A. Risk analysis in the development of pterygia. Ophthalmology 1992, 99:1056-1061.
84. Madsen-Bouterse S.A., Kowluru R.A. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev. Endocr. Metab. Disord. 2008, 9:315-327.
85. Manzer R., Qamar L., Estey T., Pappa A., Petersen D.R., Vasiliou V. Molecular cloning and baculovirus expression of the rabbit corneal aldehyde dehydrogenase (ALDH1A1) cDNA. DNA Cell. Biol. 2003, 22:329-338.
86. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 2008, 4:697-720.
87. Matt N., Dupe V., Garnier J.M., Dennefeld C., Chambon P., Mark M., Ghyselinck N.B. Retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. Development 2005, 132:4789-4800.
88. Matt N., Ghyselinck N.B., Wendling O., Chambon P., Mark M. Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm. Development 2003, 130:2083-2093.
89. Mic F.A., Molotkov A., Molotkova N., Duester G. Raldh2 expression in optic vesicle generates a retinoic acid signal needed for invagination of retina during optic cup formation. Dev. Dyn. 2004, 231:270-277.
90. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp. Eye Res. 2004, 78:553-560.
91. Moran D.J., Hollows F.C. Pterygium and ultraviolet radiation: a positive correlation. Br. J. Ophthalmol. 1984, 68:343-346.
92. Pappa A., Brown D., Koutalos Y., DeGregori J., White C., Vasiliou V. Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells. J. Biol. Chem. 2005, 280:27998-28006.
93. Pappa A., Chen C., Koutalos Y., Townsend A.J., Vasiliou V. Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic. Biol. Med. 2003, 34:1178-1189.
94. Pappa A., Estey T., Manzer R., Brown D., Vasiliou V. Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. Biochem. J. 2003, 376:615-623.
95. Pappa A., Sophos N.A., Vasiliou V. Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals. Chem. Biol. Interact. 2001, 130-132:181-191.
96. Pei Y., Reins R.Y., McDermott A.M. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Exp. Eye Res. 2006, 83:1063-1073.
97. Perez-Miller S.J., Hurley T.D. Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry 2003, 42:7100-7109.
98. Perra M.T., Maxia C., Corbu A., Minerba L., Demurtas P., Colombari R., Murtas D., Bravo S., Piras F., Sirigu P. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol. Vis. 2006, 12:1136-1142.
99. Piatigorsky J. Gene sharing in lens and cornea: facts and implications. Prog. Retin. Eye Res. 1998, 17:145-174.
100. Piatigorsky J. Multifunctional lens crystallins and corneal enzymes. More than meets the eye. Ann. N. Y. Acad. Sci. 1998, 842:7-15.
101. Piatigorsky J. Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the " refracton" hypothesis. Cornea 2001, 20:853-858.
102. Piatigorsky J. Gene Sharing and Evolution: The Diversity of Protein Functions 2007, Harvard University Press, Cambridge, MA.
103. Pinazo-Duran M.D., Verdejo C., Azorin I., Renau-Piqueras J., Iborra F.J. Colocalization of aldehyde dehydrogenases and Fe/NADPH-induced lipid peroxidation in tissue sections of rat retina. Ophthalmic Res. 2000, 32:61-68.
104. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000, 50:315-321.
105. Roberts J.E. Ocular phototoxicity. J. Photochem. Photobiol. B 2001, 64:136-143.
106. Roberts J.E. Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye Contact Lens 2011, 37:246-249.
107. Schaur R.J. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 2003, 24:149-159.
108. Schrader M., Fahimi H.D. Peroxisomes and oxidative stress. Biochim. Biophys. Acta 2006, 1763:1755-1766.
109. Shiao T., Tran P., Siegel D., Lee J., Vasiliou V. Four amino acid changes are associated with the Aldh3a1 locus polymorphism in mice which may be responsible for corneal sensitivity to ultraviolet light. Pharmacogenetics 1999, 9:145-153.
110. Sliney D.H. Optical radiation safety of medical light sources. Phys. Med. Biol. 1997, 42:981-996.
111. Stagos D., Chen Y., Brocker C., Donald E., Jackson B.C., Orlicky D.J., Thompson D.C., Vasiliou V. Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Drug Metab. Dispos. 2010, 38:1679-1687.
112. Stagos D., Chen Y., Cantore M., Jester J.V., Vasiliou V. Corneal aldehyde dehydrogenases: multiple functions and novel nuclear localization. Brain Res. Bull. 2010, 81:211-218.
113. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M., Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. U.S.A 1999, 96:9118-9123.
114. Suzuki R., Shintani T., Sakuta H., Kato A., Ohkawara T., Osumi N., Noda M. Identification of RALDH-3, a novel retinaldehyde dehydrogenase, expressed in the ventral region of the retina. Mech. Dev. 2000, 98:37-50.
115. Swamynathan S.K., Davis J., Piatigorsky J. Identification of candidate Klf4 target genes reveals the molecular basis of the diverse regulatory roles of Klf4 in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 2008, 49:3360-3370.
116. Tardieu A. Alpha-crystallin quaternary structure and interactive properties control eye lens transparency. Int. J. Biol. Macromol. 1998, 22:211-217.
117. Taylor H.R., Munoz B., West S., Bressler N.M., Bressler S.B., Rosenthal F.S. Visible light and risk of age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 1990, 88:163-173.
118. Tenkate T.D. Occupational exposure to ultraviolet radiation: a health risk assessment. Rev. Environ. Health 1999, 14:187-209.
119. Ucar D., Cogle C.R., Zucali J.R., Ostmark B., Scott E.W., Zori R., Gray B.A., Moreb J.S. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem. Biol. Interact. 2009, 178:48-55.
120. Uma L., Hariharan J., Sharma Y., Balasubramanian D. Corneal aldehyde dehydrogenase displays antioxidant properties. Exp. Eye Res. 1996, 63:117-120.
121. van den Hoogen C., van der Horst G., Cheung H., Buijs J.T., Pelger R.C., van der Pluijm G. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis. Clin. Exp. Metastasis 2011, 28:615-625.
122. Verdejo C., Marco P., Renau-Piqueras J., Pinazo-Duran M.D. Lipid peroxidation in proliferative vitreoretinopathies. Eye 1999, 13(Pt 2):183-188.
123. Verhagen C., Hoekzema R., Verjans G.M., Kijlstra A. Identification of bovine corneal protein 54 (BCP 54) as an aldehyde dehydrogenase. Exp. Eye Res. 1991, 53:283-284.
124. Wong T.Y., Foster P.J., Johnson G.J., Seah S.K., Tan D.T. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey. Am. J. Ophthalmol. 2001, 131:176-183.
125. Xiao T., Shoeb M., Siddiqui M.S., Zhang M., Ramana K.V., Srivastava S.K., Vasiliou V., Ansari N.H. Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes. J. Toxicol. Environ. Health A 2009, 72:577-584.
126. Yoshida A., Hsu L.C., Dave V. Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme 1992, 46:239-244.
127. Zigman S. Lens UVA photobiology. J. Ocul. Pharmacol. Ther. 2000, 16:161-165.